MOREPEN LABORATORIES LIMITED
L24231HP1984PLC006028
DataDelta records 6 directors, 44 financial line items, 201 NSE events, and 0 group companies for MOREPEN LABORATORIES LIMITED. Appointment dates and ownership percentages are withheld until they pass a data-quality check.
- ISIN
- INE083A01026
- NSE
- MOREPENLAB
- BSE
- 500288
- Listing
- Listed
- Status
- Active
- State
- himachal pradesh
- Class
- Public
- Industry
- Manufacturing (Metals and Chemicals, and products thereof)
Events
50 shown of 201
| Date | Type | Status | Title |
|---|---|---|---|
| 2026-09-26 | ShareholderMeeting | Announced | Morepen Laboratories Limited has informed the Exchange regarding Proceedings of 41st Annual General Meeting held on September 26, 2026 |
| 2026-09-26 | ShareholderMeeting | Announced | Please find attached the Voting Results and the Scrutinizer Report of 41st Annual General Meeting |
| 2026-09-18 | Dividend | Completed | Dividend - Re 0.20 Per Share |
| 2026-09-02 | ShareholderMeeting | Completed | Morepen Laboratories Limited has informed the Exchange about Shareholders meeting |
| 2026-08-06 | Allotment | Completed | Morepen Laboratories Limited has informed the Exchange about allotment of equity shares by Morepen RX Limited, wholly owned subsidiary, to the company |
| 2026-08-04 | BoardMeeting | Completed | Morepen Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. |
| 2026-08-04 | Disclosure | Announced | Morepen Laboratories Limited has informed the Exchange regarding a press release dated August 04, 2026, titled "Morepen clocks highest-ever quarterly revenue and earnings in Q1 FY27; EBITDA grows by 207% and PAT by 394%; CDMO enters full scale commercialization". |
| 2026-08-04 | Dividend | Completed | Morepen Laboratories Limited has informed the Exchange that Record date for the purpose of Final Dividend is 19-Sep-2026. |
| 2026-08-04 | Appointment | Announced | Morepen Laboratories Limited has informed the Exchange regarding re- appointment of Mr. Sushil Suri as Chairman & Managing Director of the company w.e.f. October 20, 2026. |
| 2026-08-04 | ShareholderMeeting | Completed | Morepen Laboratories Limited has informed the Exchange about Intimation of 41st Annual General Meeting scheduled to be held on September 26, 2026 |
| 2026-08-04 | Disclosure | Announced | Monitoring agency report for the quarter ended June 30, 2026 |
| 2026-07-28 | BoardMeeting | Completed | MOREPEN LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 04-Aug-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2026 and Other business. |
| 2026-07-28 | FinancialResults | Completed | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 2026-07-23 | NameChange | Announced | MOREPENLAB: Morepen Laboratories Limited has informed the Exchange about Name Change Of Wholly Owned Subsidiary Company from "Morepen Labs - FZCO" to "Morepen Labs FZE" |
| 2026-07-06 | BoardChange | Announced | Morepen Laboratories Limited has informed the Exchange regarding resignation of Mr. Bhola Prasad as General Manager Process Engineering & Technology Transfer, a functional head, being a Senior Management Personnel of the company w.e.f. July 06, 2026. |
| 2026-07-06 | BoardChange | Announced | Morepen Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP |
| 2026-07-01 | Disclosure | Announced | Morepen Laboratories Limited has informed the Exchange regarding a press release dated July 01, 2026, titled Morepen starts commercial supplies under its ₹ 825 Crore CDMO mandate. |
| 2026-06-30 | Disclosure | Announced | Morepen Laboratories Limited has informed the Exchange about elevation and change in designation of Mr. Sanjay Suri |
| 2026-06-26 | TradingWindow | Announced | Morepen Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2026-06-09 | Disclosure | Announced | Significant increase in volume has been observed in Morepen Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Morepen Laboratories Limited has submitted their response. |
| 2026-06-09 | Disclosure | Announced | Significant increase in volume has been observed in Morepen Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
| 2026-06-05 | Acquisition | Announced | Dilesh Roadlines Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| 2026-05-27 | Dividend | Completed | Morepen Laboratories Limited has informed the Exchange regarding a press release dated May 27, 2026, titled "Morepen Labs Q4 Net Profit Rises 69%; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10% to the shareholders for FY26.". |
| 2026-05-26 | Disclosure | Announced | Morepen Laboratories Limited has informed the Exchange about Amendment to BTA |
| 2026-05-26 | BoardMeeting | Completed | Morepen Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |
| 2026-05-26 | Dividend | Completed | Morepen Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 26, 2026, recommended Final Dividend of Rs. 0.20 per equity share. |
| 2026-05-26 | Appointment | Announced | Morepen Laboratories Limited has informed the Exchange regarding Re-appointment of Cost Auditors of the company |
| 2026-05-21 | Dividend | Completed | MOREPENLAB : 26-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 22, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 26, 2026, To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters |
| 2026-05-21 | Dividend | Completed | MOREPEN LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 26-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend. |
| 2026-05-15 | BoardMeeting | Completed | MOREPEN LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 22-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . |
| 2026-05-06 | Disclosure | Announced | Please find attached the monitoring agency report for the quarter ended March 31 2026 |
| 2026-04-23 | Disclosure | Announced | Morepen Laboratories Limited has informed the Exchange about execution of loan agreement with Shinhan Bank |
| 2026-04-17 | Disclosure | Announced | Morepen Laboratories Limited has informed the Exchange regarding a press release dated April 17, 2026, titled "Morepen Secures Fourth Consecutive USFDA Inspection with ZeroObservations (NIL 483)". |
| 2026-03-27 | TradingWindow | Announced | Morepen Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2026-03-10 | Disclosure | Announced | Morepen Laboratories Limited has informed the Exchange about execution of loan agreement and other related document with KEB Hana Bank |
| 2026-02-23 | ShareholderMeeting | Completed | Morepen Laboratories Limited has informed the Exchange regarding a press release dated February 23, 2026, titled "Morepen Bags ₹825 Crore Global Deal; Expands Into High-Growth CDMO Segment". |
| 2026-02-23 | Disclosure | Announced | Morepen Laboratories Limited has informed the Exchange about Bagging/Receiving of orders/contracts |
| 2026-02-12 | Disclosure | Announced | Morepen Laboratories Limited has informed the Exchange about Execution of Loan Agreement and other related documents with Woori Bank |
| 2026-02-10 | BoardMeeting | Completed | Morepen Laboratories Limited has submitted to the Exchange, the financial results for the quarter and nine months ended December 31, 2025. |
| 2026-02-10 | Disclosure | Announced | Please find attached the Monitoring Agency Report for the quarter ended December 31, 2025 |
| 2026-02-03 | BoardMeeting | Completed | MOREPEN LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . |
| 2026-02-03 | FinancialResults | Completed | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 2025-12-31 | TradingWindow | Announced | Morepen Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2025-11-14 | Disclosure | Announced | Please find attached the Monitoring Agency Report for the quarter ended September 30, 2025 |
| 2025-11-14 | BoardMeeting | Completed | Morepen Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. |
| 2025-11-10 | Disclosure | Announced | Morepen Laboratories Limited has informed the Exchange about Execution of Agreement for availing of unsecured term loan facility from Kookmin Bank |
| 2025-11-07 | FinancialResults | Completed | To consider and approve un-audited standalone and consolidated financial results of the company for the quarter and half year ended 30th September 2025 |
| 2025-11-07 | BoardMeeting | Completed | MOREPEN LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 . |
| 2025-09-26 | TradingWindow | Announced | Morepen Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 2025-09-08 | Acquisition | Announced | Morepen Laboratories Limited has informed the Exchange about Acquisition |
Directors
6 shown of 6
| Name | DIN | Designation | Status |
|---|---|---|---|
| Board has re-appointed Mr. Sushil Suri | 00012028 | Managing Director | Active |
| Praveen Kumar Dutt Non | 06712574 | Executive Independent Director Chairman | Active |
| Ranjit Khattar Non | 00726997 | Executive Independent Director Member | Active |
| Sanjay Suri as Whole | 00041590 | Time Director (presently Managing Director) lead our day-to-day operational execution, the Board maintains a | Ceased |
| Savita | 08764773 | Independent Director | Active |
| Sharad Jain Non | 06423452 | Executive Independent Director Member | Active |
Financials
44 shown of 44
| Year | Metric | Value | Unit |
|---|---|---|---|
| 2025-26 | CostOfMaterials | 1,04,310.57 | Crore |
| 2025-26 | CostOfMaterials | 1,04,310.57 | Lakhs |
| 2025-26 | Depreciation | 3,643.47 | Lakhs |
| 2025-26 | Depreciation | 2,930.81 | Crore |
| 2025-26 | EmployeeBenefits | 23,273.94 | Lakhs |
| 2025-26 | EmployeeBenefits | 20,627.7 | Crore |
| 2025-26 | FinanceCosts | 1,641.37 | Lakhs |
| 2025-26 | FinanceCosts | 1,609.71 | Crore |
| 2025-26 | NetProfit | 9,564.65 | Lakhs |
| 2025-26 | NetProfit | 6,605.75 | Crore |
| 2025-26 | OtherIncome | 2,149.51 | Crore |
| 2025-26 | OtherIncome | 2,131.41 | Lakhs |
| 2025-26 | ProfitBeforeTax | 8,926.42 | Crore |
| 2025-26 | ProfitBeforeTax | 11,992 | Lakhs |
| 2025-26 | Revenue | 1,68,119.5 | Crore |
| 2025-26 | Revenue | 1,80,569.15 | Lakhs |
| 2025-26 | Tax | 2,427.35 | Lakhs |
| 2025-26 | Tax | 2,320.67 | Crore |
| 2025-26 | TotalExpenses | 1,61,452.18 | Crore |
| 2025-26 | TotalExpenses | 1,73,291.1 | Lakhs |
| 2025-26 | TotalIncome | 1,82,700.56 | Lakhs |
| 2025-26 | TotalIncome | 1,70,269.01 | Crore |
| 2024-25 | CostOfMaterials | 99,918.31 | Crore |
| 2024-25 | CostOfMaterials | 99,918.31 | Lakhs |
| 2024-25 | Depreciation | 2,444.21 | Crore |
| 2024-25 | Depreciation | 2,898.17 | Lakhs |
| 2024-25 | EmployeeBenefits | 17,722.43 | Crore |
| 2024-25 | EmployeeBenefits | 20,891.39 | Lakhs |
| 2024-25 | FinanceCosts | 710.29 | Crore |
| 2024-25 | FinanceCosts | 834.29 | Lakhs |
| 2024-25 | NetProfit | 10,157.52 | Crore |
| 2024-25 | NetProfit | 11,801.54 | Lakhs |
| 2024-25 | OtherIncome | 1,571.96 | Crore |
| 2024-25 | OtherIncome | 1,836.37 | Lakhs |
| 2024-25 | ProfitBeforeTax | 13,758.56 | Crore |
| 2024-25 | ProfitBeforeTax | 15,510.94 | Lakhs |
| 2024-25 | Revenue | 1,81,157.58 | Lakhs |
| 2024-25 | Revenue | 1,55,453.53 | Crore |
| 2024-25 | Tax | 3,601.04 | Crore |
| 2024-25 | Tax | 3,709.4 | Lakhs |
| 2024-25 | TotalExpenses | 1,67,483.01 | Lakhs |
| 2024-25 | TotalExpenses | 1,43,266.93 | Crore |
| 2024-25 | TotalIncome | 1,82,993.95 | Lakhs |
| 2024-25 | TotalIncome | 1,57,025.49 | Crore |
Group companies
0 shown of 0
| Company | Relationship | Country |
|---|